Related Experiment Video
Updated: May 21, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Cross-regulation of protein stability by p53 and nuclear receptor SHP
Zhihong Yang1, Yuxia Zhang, Jongsook Kim Kemper
1Departments of Medicine and Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Abstract:
We report here a novel interplay between tumor suppressor p53 and nuclear receptor SHP that controls p53 and SHP stability. Overexpression of p53 causes rapid SHP protein degradation, which does not require the presence of Mdm2 and is mediated by the proteosome pathway. Overexpressing SHP alone does not affect p53 stability. However, SHP destabilizes p53 by augmentation of Mdm2 ubiquitin ligase activity toward p53. The single amino acid substitution in the SHP protein SHPK170R increases SHP binding to p53 relative to SHP wild-type, whereas SHPG171A variant shows a diminished p53 binding. As a result of the cross-regulation, the tumor suppressor function of p53 and SHP in inhibition of colon cancer growth is compromised. Our findings reveal a unique scenario for a cross-inhibition between two tumor suppressors to keep their expression and function in check.
Insights
Tumor suppressors p53 and SHP (small heterodimer partner) cross-regulate each other's stability and function. This novel interplay impacts their tumor suppressor roles, particularly in colon cancer growth inhibition.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- The tumor suppressor p53 plays a critical role in preventing cancer.
- The nuclear receptor SHP is involved in various metabolic and cellular processes.
- Understanding the regulation of tumor suppressor stability is crucial for cancer therapy.
Purpose of the Study:
- To investigate the novel interplay between tumor suppressor p53 and nuclear receptor SHP.
- To elucidate the mechanisms controlling the stability of p53 and SHP.
- To determine the impact of this cross-regulation on tumor suppressor functions in colon cancer.
Main Methods:
- Protein expression and degradation assays.
- Proteasome pathway inhibition.
- Ubiquitin ligase activity assays.
- Site-directed mutagenesis of SHP protein.
- Colon cancer cell line studies.
Main Results:
- Overexpression of p53 leads to proteasome-mediated degradation of SHP, independent of Mdm2.
- SHP destabilizes p53 by enhancing Mdm2 ubiquitin ligase activity.
- Specific mutations in SHP (SHPK170R, SHPG171A) alter its binding affinity to p53.
- The cross-regulation between p53 and SHP compromises their tumor suppressor functions in colon cancer.
Conclusions:
- A novel cross-inhibitory mechanism exists between tumor suppressors p53 and SHP.
- This interplay regulates the stability and function of both proteins.
- The findings reveal a unique regulatory network impacting colon cancer progression.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Abnormal Proliferation
Negative Regulator Molecules
Regulation of Nuclear Protein Sorting
Regulation of the Unfolded Protein Response

